NanoVax intranasal vaccine platform
BlueWillow Biologics, established as NanoBio in 2000, develops intranasal vaccines using the NanoVax platform for respiratory and sexually transmitted infections, advancing candidates into clinical trials.
Данные отсутствуют
FAQ отсутствуют.